Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

BMS Study Connect Contact Center www.BMSStudyConnect.com 855-907-3286
Clinical.Trials@bms.com


First line of the email MUST contain the NCT# and Site #.


Study Location:

Find another location


Questions to ask
Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Back

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Recruiting

Open to: ALL

Age: All

London London Leeds Manchester Withington Shirley Southampton

Medical Conditions

This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study.

Participants who received at least one GM T cell infusion will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Jul 2018 Nov 2036

INTERVENTIONAL

Intervention Type : GENETIC
Intervention Description : No investigational product will be administered

Intervention Arm Group : Participants exposed to Gene-modified (GM) T cell therapy;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • UCL Cancer Institute
    London
    WC1E 6BT
  • Kings College Hospital
    London
    SE5 9RS
  • Local Institution - 10850
    Leeds
    LS9 7TF
  • Christie Hospital Nhs Trust
    Manchester Withington
    M20 4BX
  • Somers Cancer Research Building
    Shirley Southampton
    SO16 6YD

First line of the email MUST contain the NCT# and Site #.


BMS Study Connect Contact Center www.BMSStudyConnect.com 855-907-3286
Clinical.Trials@bms.com



The study is sponsored by Celgene



We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?
Read full details for Trial ID: NCT03435796
Last updated 21 March 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.   

Back to the top